Managing serum phosphate in haemodialysis patients: Time for an innovative approach?

European Journal of Clinical Nutrition

Volumn 68, Issue 3, 2014, Pages 392-396

  Collinson, A ^a   McMullan, M ^a   Tse, W Y ^b   Sadler, H ^b  

^a UNIVERSITY OF PLYMOUTH   (United Kingdom)

^b DERRIFORD HOSPITAL   (United Kingdom)

Author keywords

adherence; age; dialysis; serum phosphate

Indexed keywords

CALCIUM; CINACALCET; PARATHYROID HORMONE; PHOSPHATE; UREA; YOGHURT;

ADULT; AGE; AGED; ARTICLE; AWARENESS; BANANA; BUTTER; CALCIUM BLOOD LEVEL; CARROT; CHEESE; CONTROLLED STUDY; DIETARY COMPLIANCE; FATIGUE; FEMALE; GENDER; HEMODIALYSIS PATIENT; HUMAN; HYPERPHOSPHATEMIA; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; NAUSEA; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTPATIENT; PARATHYROID HORMONE BLOOD LEVEL; PATIENT COUNSELING; PATIENT EDUCATION; PHOSPHATE BLOOD LEVEL; PHOSPHATE INTAKE; PRESCRIPTION; PRURITUS; QUESTIONNAIRE; UREA BLOOD LEVEL;

ADOLESCENT; ADULT; AGED; CALCIUM; FEMALE; GREAT BRITAIN; HUMANS; HYPERPHOSPHATEMIA; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PARATHYROID HORMONE; PHOSPHATES; PHOSPHORUS; QUESTIONNAIRES; RENAL DIALYSIS; YOUNG ADULT;

EID: 84895787525     PISSN: 09543007     EISSN: 14765640     Source Type: Journal    
DOI: 10.1038/ejcn.2013.283     Document Type: Article

References (32)

1. Block G, Klassen PS, Lazarus JM, Ofsthun N, Lowrie EG, Chertow GM. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 2004; 15: 2208-2218.
2. UK Renal Association. Clinical Practice Guideline: CKD-Mineral and Bone Bisorders (CKD-MBD). The Renal Association: Oxford, UK, 2010.
3. Touissant ND, Pedagogos E, Beavis J, Becker GJ, Polkinghorne KR, Kerr PG. Improving CKD-MBD management in haemodialysis patients: barrier analysis for implementing better practice. Nephrol Dial Transplant 2011; 26: 1319-1326.
4. Lynch KE, Lynch R, Curhan GC, Brunelli SM. Prescribed dietary phosphate restriction and survival among haemodialysis patients. Clin J Am Soc Nephrol 2011; 6: 620-629.
5. Cupisti A, Ferretti V, D'Alessandro C, Petrone I, Di Giorgio A, Meola M et al. Nutritional knowledge in haemodialysis patients and nurses: focus on phosphorus. J Ren Nutr 2012; 22: 541-546.
6. Kugler C, Maeding I, Russell CL. Non-adherence in patients on chronic haemodialysis: an international comparison study. J Nephrol 2011; 24: 366-375.
7. Nerbass FB, Morais JG, dos Santos RG, Kruger TS, Koene TT, da Luz Filho HA. Adherence and knowledge about hyperphosphataemia treatment in haemodialysis patients with hyperphosphataemia. J Bras Nefrol 2010; 32: 149-155.
8. Poduval RD, Wolgemuth D, Ferrel J, Hammes MS. Hyperphosphataemia in dialysis patients: is there a role for focused counselling? J Ren Nutr 2003; 13: 219-223.
9. Chui Y, Teitelbaum I, Misra M, de Leon EM, Adzize T, Mehrotra R. Pill burden, adherence, hyperphosphataemia, and quality of life in maintenance dialysis patients. Clin J Am Soc Nephrol 2009; 4: 1089-1096.
10. Tomasello S, Dhupar S, Sherman RA. Phosphate binders. K/DOQI guidelines and compliance: the unfortunate reality. Dialysis Transplant 2004; 33: 236-242.
11. Karamanidou C, Clatworthy J, Weinman J, Horne R. A systematic review of the prevalence and determinants of nonadherence to phosphate binding medication in patients with end-stage renal disease. BMC Nephrol 2008; 9: 2.
12. Pruthi R, Pitcher D, Dawnay A. 14th Annual Report of the Renal Association. Renal Registry: Bristol, UK, 2011.
13. Bame SI, Petersen N, Wray NP. Variation in hemodialysis patient compliance according to demographic characteristics. Soc Sci Med 1993; 37: 1035-1043.
14. Bossola M, Muscaritoli M, Tazza L, Panocchia N, Liberatori M, Giungi S et al. Variables associated with reduced dietary intake in hemodialysis patients. J Ren Nutr 2005; 15: 244-252.
15. DiMatteo MR. Variations in patients' adherence to medical recommendations: a quantitative review of 50 years of research. Med Care 2004; 42: 200-209.
16. Sun Y, Cai H, Bai J, Zhao H, Miao Y. Endoscopic total parathyroidectomy and partial parathyroid tissue autotransplantation for patients with secondary hyperparathyroidism: a new surgical approach. World J Surg 2009; 33: 1674-1679.
17. Mazzaferro S, Pasquali M, Farcomeni A, Vestri AR, Filippini A, Romani AM et al. Parathyroidectomy as a therapeutic tool for targeting the recommended NKF-K/DOQITM ranges for serum calcium, phosphate and parathyroid hormone in dialysis patients. Nephrol Dial Transplant 2008; 23: 2319-2323.
18. Leypoldt JK. Kinetics of beta2-microglobulin and phosphate during haemodialysis: effects of treatment frequency and duration. Semin Dial 2005; 18: 401-408.
19. Stamatakis MK, Pecora PG, Gunel E. Factors influencing adherence in chronic dialysis patients with hyperphosphatemia. J Ren Nutr 1997; 7: 144-148.
20. Park K, Choi-Kwon S, Sim YM, Kim SB. Comparison of dietary compliance and dietary knowledge between older and younger Korean haemodialyis patients. J Ren Nutr 2008; 18: 415-423.
21. Durose CL, Holdsworth M, Watson V, Przygrodzka F. Knowledge of dietary restrictions and the medical consequences of noncompliance by patients on haemodialysis are no predictive of dietary compliance. J Am Diet Assoc 2004; 104: 35-41.
22. Goldfarb S. Renal Osteodystrophy, Disorders of divalent ions, and nephrolithiasis. Nephrology Self-Assessment Program. J Am Soc Nephrol 2005; 4: 245-279.
23. Reddy V, Sethi N, Scally A, Symes F, Steel J, Mumtaz R et al. Dietitian-led education programme to improve phosphate control in a single-centre haemodialysis population. J Ren Nutr 2009; 19: 314-320.
24. Cupisti A, D'Alessandro C, Baldi R, Barsotti G. Dietary habits and counselling focused on phosphate intake in haemodialysis patients with hyperphosphataemia. J Ren Nutr 2004; 14: 220-225.
25. National Institute for Health and Care Excellence (NICE). Hyperphosphataemia in Chronic Kidney Disease Management of Hyperphosphataemia in Patients with Stage 4 or 5 Chronic Kidney Disease. CG157 National Institute for Health and Care Excellence: London, UK, 2013.
26. Kuhlmann MK, Hoechst S, Landthaler I. Patient empowerment in the management of hyperphosphataemia. Int J Art Org 2007; 30: 1008-1013.
27. Morey B, Walker R, Devenport A. More dietetic time, better outcome? A randomised prospective study investigating the effect of more dietetic time on phosphate control in end-stage kidney failure haemodialysis patients. Nephron Clin Pract 2008; 109: 173-180.
28. Kalantar-Zadeh K. Patient education for phosphorus management in chronic kidney disease. Patient Prefer Adherence 2013; 7: 379-390.
29. Caldeira D, Amaral T, David C, Sampaio C. Educational strategies to reduce serum phosphorus in hyperphosphataemic patients with chronic kidney disease: systematic review with meta-analysis. J Ren Nutr 2011; 21: 285-294.
30. Karamanidou C, Weinman J, Hore R. Improving haemodialysis patients' understanding of phosphate binding medication: a pilot study of a psycho-educational intervention designed to change patients' perceptions of the problem and treatment. Brit J Health Psych 2008; 13: 205-214.
31. Carlson S, Benner D, Kwiterovich C, Van Wyck D. Patient experience with an interactive web-based phosphorous education tool. J Ren Nutr 2011; 21: 205.
32. Elwood D. The right technology improves patient education and satisfaction. Mobile health 360. 2011. (accessed December 7, 2012 at http://www.mhealth360.com/2011/03/14/the-right-technology-improves-patient- education-and-satisfaction/).